Li Ching-Chia, Chang Tu-Hao, Wu Wen-Jeng, Ke Hung-Lung, Huang Shu-Pin, Tsai Pei-Chien, Chang Shun-Jen, Shen Jung-Tsung, Chou Yii-Her, Huang Chun-Hsiung
Department of Urology, Chung-Ho Memorial Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Eur Urol. 2008 Nov;54(5):1127-34. doi: 10.1016/j.eururo.2008.01.054. Epub 2008 Jan 28.
To follow up the long-term prognosis of patients who underwent nephroureterectomy for primary upper urinary tract (UUT) cancer and to evaluate the predictive factors of tumour recurrence and survival.
Between January 1990 and June 2005, 260 patients with primary UUT transitional cell carcinoma (TCC) underwent radical nephroureterectomy at our institution. The medical records of these patients were retrospectively reviewed. The clinical and histopathological data were analyzed to evaluate predictive factors.
The median follow-up time was 52 mo. In total, 89 patients (34.1%) developed subsequent bladder tumours. Predictive factors of bladder tumour recurrence were being male and having renal insufficiency. Local recurrence developed in 16 patients (6.2%); only the tumour stage was significantly associated with local recurrence. Metachronous contralateral UUT tumour was diagnosed in 12 patients (4.6%), with gender being the only predictive factor. Of the 260 patients, 167 (63.9%) were disease-free and alive at a median follow-up of 56.5 mo, and 45 (17.2%) died of urothelial cancer at a median period of 20 mo. Only the tumour stage was a prognostic factor to predict cancer-specific survival.
In patients with UUT-TCC after radical nephroureterectomy, tumour stage is the only prognostic factor for both local recurrence and cancer-specific survival. Male patients with renal insufficiency should be alerted to the possibility of bladder tumour recurrence. Because female patients were more likely to develop contralateral recurrences, renal ultrasonography, intravenous pyelography, or retrograde pyelography should be performed more frequently for female patients who live in the high-prevalence area.
对接受原发性上尿路(UUT)癌肾输尿管切除术的患者进行长期预后随访,并评估肿瘤复发和生存的预测因素。
1990年1月至2005年6月期间,260例原发性UUT移行细胞癌(TCC)患者在我院接受了根治性肾输尿管切除术。对这些患者的病历进行回顾性分析。分析临床和组织病理学数据以评估预测因素。
中位随访时间为52个月。共有89例患者(34.1%)出现了后续膀胱肿瘤。膀胱肿瘤复发的预测因素为男性和肾功能不全。16例患者(6.2%)出现局部复发;仅肿瘤分期与局部复发显著相关。12例患者(4.6%)诊断为异时性对侧UUT肿瘤,性别是唯一的预测因素。260例患者中,167例(63.9%)在中位随访56.5个月时无疾病生存,45例(17.2%)在中位20个月时死于尿路上皮癌。仅肿瘤分期是预测癌症特异性生存的预后因素。
在根治性肾输尿管切除术后的UUT-TCC患者中,肿瘤分期是局部复发和癌症特异性生存的唯一预后因素。应提醒肾功能不全的男性患者注意膀胱肿瘤复发的可能性。由于女性患者更易发生对侧复发,对于生活在高发地区的女性患者,应更频繁地进行肾脏超声、静脉肾盂造影或逆行肾盂造影检查。